MESULERGINE AND LEVODOPA IN PARKINSON'S DISEASE
✍ Scribed by H. Teräväinen; M. Hietanen; J. Huttunen; S. Pihl
- Book ID
- 114781748
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 87 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0001-6314
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Three patients with Parlcinson's disease, optimally treated with levodopdcabidopa (LDKD) tablets, but experiencing severe motor fluctuations, were administered a solution of levodopd carbidopalascorbic acid (LCAS) orally at intervals ranging from 30 to 60 minutes. Patients were rated half-hourly to
## Abstract To further characterize the short‐term levodopa response in early PD, we performed a retrospective analysis of the ELLDOPA study which randomized 361 early PD subjects to placebo, levodopa 150, 300, or 600 mg/day. We evaluated change in UPDRS motor scores (UPDRSm) from baseline to weeks